
The FDA approved adrabetadex for infantile-onset NPC based on a 55% lower risk of death vs external controls, with a boxed warning for hearing loss.
Managing babies of GBS-positive mothers/Divorce and domestic violence/Psychiatric disease and medication: The general pediatrician?s role/Car crashes: Understanding the physics/The merit of yearly sports physicals






